Home Overview Press Room Blog Publications For Students about us

Patents & Other IP : Displaying 208-217 of 349

23andMe Gets Into the Breast Cancer Testing Businessby Osagie K. ObasogieBiopolitical TimesFebruary 23rd, 2009Google-backed 23andMe, a leader in the recreational genetics sector, has added a new service: telling its customers whether they have a genetic variant that may significantly increase their chance of developing breast and ovarian cancer.
Africans’ DNA could be abusedby Bobby JordanThe Times (South Africa)February 14th, 2009South African researchers and traditional leaders fear US scientists will soon start patenting the genes of local ethnic groups, many of whom have donated blood samples as part of a worldwide genome-mapping project.
Hwang to Back His Own Inventionsby Kim Tong-hyungThe Korea TimesJanuary 12th, 2009Getting a shot at redemption, Hwang's colleague at the Sooam Biotech Research Center confirmed that Seoul National University had handed over the intellectual property rights for Hwang's claimed inventions in human stem cell research to H-Bion.
SNU drops bid for stem cell patentby Ser Myo-jaJoongAng DailyDecember 31st, 2008Seoul National University has decided to end efforts to obtain overseas patents for stem cell technology of disgraced scientist Hwang Woo-suk
European agency rules against stem cell patentsby Michael KahnReutersNovember 27th, 2008European regulators ruled against allowing a patent on developing human embryonic stem cells.
House Panel Discusses International Limits On Gene Study to Prevent Competitive Abuse[Quotes CGS's Richard Hayes]The Bureau of National AffairsJune 21st, 2008An international consensus on this research and its application must be achieved, panelists told a House subcommittee on terrorism.
Letting Sleeping Dogs Lieby Jesse ReynoldsBiopolitical TimesJune 12th, 2008The leadership of the California stem cell research agency has commissioned a new economic report. Any realistic economic analysis may not be an effective shield in Sacramento during a period of drastic budget cuts, and by reviving past controversy, revisiting the economic argument may backfire.
Dog Cloning and Intellectual Propertyby Marcy Darnovsky and Jesse ReynoldsBiopolitical TimesJune 5th, 2008In the minor flurry of stories last month about an on-line auction of dog cloning services, the issue of intellectual property was completely overlooked. That’s too bad, since the cloning business, like so many others, is best understood by following the money.
Unseen Rise of ‘Body Shopping’by Donna DickensonThe Sunday TimesApril 20th, 2008Good science can’t be rushed, and the commercialisation of biotechnology needs proper examination. The problem is that parliament is too busy arguing about God to pay much attention.
Another Bill to Reform the California Stem Cell Research Programby Jesse ReynoldsBiopolitical TimesMarch 4th, 2008For the fourth year in a row, the Democratic chair of the California Senate Health Committee, currently Sheila Kuehl, and her Republican colleague, George Runner, have introduced a bill to address some of the flaws in the California stem cell research program.
Displaying 208-217 of 349  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760